Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the 1933 Act on the basis of being a “bad actor” as that term is defined in the Rule 506(d)(4) under the SEC 1933 Act.
Appears in 11 contracts
Sources: Securities Purchase Agreement (Crypto Co), Securities Purchase Agreement (Resonate Blends, Inc.), Securities Purchase Agreement (Bio Key International Inc)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the 1933 Act on the basis of being a “bad actor” as that term is defined described in the Rule 506(d)(4506(d) under the SEC 1933 Act.
Appears in 4 contracts
Sources: Securities Purchase Agreement (Verus International, Inc.), Securities Purchase Agreement (Verus International, Inc.), Securities Purchase Agreement (Verus International, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the 1933 Act on the basis of being a “bad actor” as that term is defined in the Rule 506(d)(4) Regulation D under the SEC 1933 Act.
Appears in 3 contracts
Sources: Note Purchase Agreement (Algae Dynamics Corp.), Note Purchase Agreement (Algae Dynamics Corp.), Note Purchase Agreement (Xfit Brands, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the 1933 Securities Act as amended on the basis of being a “bad actor” as that term is defined in the by Rule 506(d)(4506(d) under the SEC 1933 Act.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Adhera Therapeutics, Inc.), Securities Purchase Agreement (Adhera Therapeutics, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the 1933 Act on the basis of being a “bad actor” as that term is defined in the Rule 506(d)(4) under the SEC 1933 Act.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Organicell Regenerative Medicine, Inc.), Securities Purchase Agreement (Organicell Regenerative Medicine, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the 1933 Act on the basis of being a “bad actor” as that term is defined in the Rule 506(d)(4) under the SEC 1933 Act.
Appears in 1 contract
Sources: Securities Purchase Agreement (Kaival Brands Innovations Group, Inc.)
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the 1933 Act on the basis of being a “"bad actor” " as that term is defined in the Rule 506(d)(4) under the SEC 1933 Act.
Appears in 1 contract
Sources: Securities Purchase Agreement (SusGlobal Energy Corp.)